Status:
COMPLETED
Patient Blood Management In CARdiac sUrgical patientS
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Anemia
Blood Loss Anemia
Eligibility:
All Genders
18+ years
Brief Summary
Nowadays up to 40% of patients undergoing cardiac surgery receives at least 1 unit of red blood cell transfusion during surgery or during the first week after surgery. Moreover up to 40% of these pati...
Detailed Description
Anemia is defined by the World Health Organization (WHO) as a value of hemoglobin (Hb) \< 130 g/L in men and \< 120 g/L in women. Anemia in surgical patients is a common and serious problem, in fact u...
Eligibility Criteria
Inclusion
- \- all adult patients candidate to planned heart surgery
Exclusion
- Pregnancy
- Know allergy to iron, or B vitamin, or folic acid
- Hyperferritinemia (ferritin blood value \> 300 ng/ml).
- patient's refusal
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
479 Patients enrolled
Trial Details
Trial ID
NCT04744181
Start Date
January 18 2021
End Date
January 31 2022
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FPG Fondazione Policlinico Gemelli IRCCS
Roma, roma, Italy, 00100